Bayview Legacy LLC sells 192,686 Arteris shares

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported open-market sales of 192,686 shares of Arteris common stock.

Rhea-AI Filing Summary

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported open-market sales of 192,686 shares of Arteris common stock. The trades occurred on July 2, 2026 across eight transactions at weighted average prices between $34.77 and $43.24 per share. The filing notes that these sales were made pursuant to a Rule 10b5-1 trading plan adopted by Bayview’s manager, K. Charles Janac, on December 12, 2025, indicating the transactions were pre-scheduled rather than opportunistic.

Insider Trade Summary 10b5-1

Net Seller: 192,686 shares

Net Sell 8 txns

Insider Bayview Legacy, LLC

Role 10% Owner

Sold 192,686 shs ($7.00M)

Type	Security	Shares	Price	Value
Sale	Common Stock	11,000	$37.6074	$414K
Sale	Common Stock	39,880	$36.6961	$1.46M
Sale	Common Stock	26,348	$35.6723	$940K
Sale	Common Stock	80,042	$34.7706	$2.78M
Sale	Common Stock	24,691	$38.8891	$960K
Sale	Common Stock	5,482	$39.7237	$218K
Sale	Common Stock	2,500	$40.7832	$102K
Sale	Common Stock	2,743	$43.2358	$119K

Holdings After Transaction: Common Stock — 8,555,047 shares (Indirect, See Footnote)

Footnotes (11)

1. F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on December 12, 2025.
2. F10. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $40.44 to $40.90 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F11. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.57 to $43.51 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. F2. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.
5. F3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $37.20 to $38.17 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. F4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.
7. F5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $36.20 to $37.19 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
8. F6. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $35.20 to $36.19 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
9. F7. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.20 to $35.19 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
10. F8. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.27 to $39.25 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
11. F9. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $39.30 to $40.29 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 192,686 shares Number of transactions: 8 sales Highest reported weighted average price: $43.2358/share +4 more

7 metrics

Shares sold 192,686 shares Total common shares sold on July 2, 2026

Number of transactions 8 sales Open-market common stock sales on July 2, 2026

Highest reported weighted average price $43.2358/share One of the July 2, 2026 sale prices

Lowest reported weighted average price $34.7706/share One of the July 2, 2026 sale prices

Net share direction -192,686 shares Net-sell activity per transaction summary

10b5-1 plan adoption date December 12, 2025 Adoption date of trading plan governing these sales

Insider status 10% owner Bayview Legacy, LLC ownership classification

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, beneficial ownership, voting and dispositive power, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan that was adopted..."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported in Column 4 is a weighted average sale price."

beneficial ownership financial

"given his beneficial ownership of the reported security through Bayview Legacy, LLC..."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

voting and dispositive power regulatory

"is deemed to have voting and dispositive power over the shares..."

open market or private transaction financial

"Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bayview Legacy, LLC report in its latest Form 4 for Arteris (AIP)?

Bayview Legacy, LLC reported selling 192,686 shares of Arteris common stock in eight open-market transactions on July 2, 2026. These indirect sales reflect activity by a 10% owner and were executed under a pre-established Rule 10b5-1 trading plan.

How many Arteris (AIP) shares did Bayview Legacy, LLC sell and at what prices?

Bayview Legacy, LLC sold 192,686 Arteris shares in total. The eight reported open-market transactions used weighted average sale prices ranging from about $34.77 to $43.24 per share, with detailed price ranges available in the filing’s weighted-average footnotes.

Were Bayview Legacy, LLC’s Arteris (AIP) share sales made under a Rule 10b5-1 plan?

Yes. The Form 4 states the transactions were made under a Rule 10b5-1 trading plan adopted on December 12, 2025. Such plans pre-schedule trades, meaning the timing of these July 2, 2026 sales was set in advance rather than decided spontaneously.

Is Bayview Legacy, LLC a significant shareholder of Arteris (AIP)?

Bayview Legacy, LLC is identified in the filing as a 10% owner of Arteris. The reported transactions involve indirect holdings, with K. Charles Janac controlling Bayview as its manager and deemed to have voting and dispositive power over its beneficially owned shares.

What role does K. Charles Janac play in Bayview Legacy, LLC’s Arteris (AIP) holdings?

The footnotes explain that K. Charles Janac is the manager of Bayview Legacy, LLC and is deemed to have voting and dispositive power over its Arteris shares. He also filed a separate Form 4 reporting the same transactions due to his beneficial ownership through Bayview.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 05:26 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bayview Legacy, LLC

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CALIFORNIA 95008

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/02/2026		S(1)(2)		11,000	D	$37.6074(3)	8,736,733	I	See Footnote(4)
Common Stock	07/02/2026		S(1)(2)		39,880	D	$36.6961(5)	8,696,853	I	See Footnote
Common Stock	07/02/2026		S(1)(2)		26,348	D	$35.6723(6)	8,670,505	I	See Footnote
Common Stock	07/02/2026		S(1)(2)		80,042	D	$34.7706(7)	8,590,463	I	See Footnote
Common Stock	07/02/2026		S(1)(2)		24,691	D	$38.8891(8)	8,565,772	I	See Footnote
Common Stock	07/02/2026		S(1)(2)		5,482	D	$39.7237(9)	8,560,290	I	See Footnote
Common Stock	07/02/2026		S(1)(2)		2,500	D	$40.7832(10)	8,557,790	I	See Footnote
Common Stock	07/02/2026		S(1)(2)		2,743	D	$43.2358(11)	8,555,047	I	See Footnote

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on December 12, 2025.

2. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.

3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $37.20 to $38.17 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.

5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $36.20 to $37.19 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

6. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $35.20 to $36.19 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

7. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.20 to $35.19 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

8. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.27 to $39.25 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

9. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $39.30 to $40.29 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

10. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $40.44 to $40.90 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

11. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.57 to $43.51 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ K. Charles Janac	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)